George H Conrades - Net Worth and Insider Trading
George H Conrades Net Worth
The estimated net worth of George H Conrades is at least $101 Million dollars as of 2024-04-28. George H Conrades is the Director of Akamai Technologies Inc and owns about 969,507 shares of Akamai Technologies Inc (AKAM) stock worth over $99 Million. George H Conrades is the Director of Oracle Corp and owns about 17,836 shares of Oracle Corp (ORCL) stock worth over $2 Million. George H Conrades is also the Director of Harley-Davidson Inc and owns about 0 shares of Harley-Davidson Inc (HOG) stock worth over $0. Details can be seen in George H Conrades's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George H Conrades has not made any transactions after 2023-11-13 and currently still holds the listed stock(s).
Transaction Summary of George H Conrades
George H Conrades Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George H Conrades owns 6 companies in total, including Cyclerion Therapeutics Inc (CYCN) , Oracle Corp (ORCL) , and Akamai Technologies Inc (AKAM) among others .
Click here to see the complete history of George H Conrades’s form 4 insider trades.
Insider Ownership Summary of George H Conrades
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CYCN | Cyclerion Therapeutics Inc | 2021-06-24 | director |
ORCL | Oracle Corp | 2023-11-13 | director |
AKAM | Akamai Technologies Inc | 2014-11-26 | director & Executive Chairman |
HOG | Harley-Davidson Inc | 2015-08-14 | director |
IRWD | Ironwood Pharmaceuticals Inc | 2010-02-02 | director |
CAH | Cardinal Health Inc | 2003-08-05 | director |
George H Conrades Latest Holdings Summary
George H Conrades currently owns a total of 3 stocks. Among these stocks, George H Conrades owns 969,507 shares of Akamai Technologies Inc (AKAM) as of November 26, 2014, with a value of $99 Million and a weighting of 97.92%. George H Conrades owns 17,836 shares of Oracle Corp (ORCL) as of November 13, 2023, with a value of $2 Million and a weighting of 2.08%. George H Conrades also owns 0 shares of Harley-Davidson Inc (HOG) as of August 14, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of George H Conrades
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AKAM | Akamai Technologies Inc | 2014-11-26 | 969,507 | 101.68 | 98,579,472 |
ORCL | Oracle Corp | 2023-11-13 | 17,836 | 117.21 | 2,090,558 |
HOG | Harley-Davidson Inc | 2015-08-14 | 0 | 34.75 | 0 |
Holding Weightings of George H Conrades
George H Conrades Form 4 Trading Tracker
According to the SEC Form 4 filings, George H Conrades has made a total of 0 transactions in Akamai Technologies Inc (AKAM) over the past 5 years. The most-recent trade in Akamai Technologies Inc is the sale of 22,340 shares on November 26, 2014, which brought George H Conrades around $1 Million.
According to the SEC Form 4 filings, George H Conrades has made a total of 1 transactions in Oracle Corp (ORCL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Oracle Corp is the sale of 4,650 shares on November 13, 2023, which brought George H Conrades around $524,846.
According to the SEC Form 4 filings, George H Conrades has made a total of 0 transactions in Harley-Davidson Inc (HOG) over the past 5 years. The most-recent trade in Harley-Davidson Inc is the sale of 3,873 shares on August 14, 2015, which brought George H Conrades around $230,134.
Insider Trading History of George H Conrades
- 1
George H Conrades Trading Performance
GuruFocus tracks the stock performance after each of George H Conrades's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George H Conrades is 14.18%. GuruFocus also compares George H Conrades's trading performance to market benchmark return within the same time period. The performance of stocks bought by George H Conrades within 3 months outperforms 7 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George H Conrades's insider trading performs compared to the benchmark.
Performance of George H Conrades
Average Return
50.52%
Outperforming Transactions
78%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 2.96 | 14.18 | 25.9 | 50.52 | 23.38 | 14.16 |
Relative Return to S&P 500(%) | 3.35 | 15.68 | 21.78 | 38.42 | 17.86 | 8.46 |
George H Conrades Ownership Network
Ownership Network List of George H Conrades
Ownership Network Relation of George H Conrades
George H Conrades Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
George H Conrades is the director of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , director & Chief Executive Officer Peter M Hecht , and 10 percent owner Slate Path Capital Lp .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
Over the past 18 months, George H Conrades made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
George H Conrades Mailing Address
Above is the net worth, insider trading, and ownership report for George H Conrades. You might contact George H Conrades via mailing address: 500 Technology Square, Fifth Floor, Cambridge Ma 02139.